MSU
GILD icon

Maple Securities USA’s Gilead Sciences GILD Stock Holding History

Maple Securities USA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,196
Closed -$1.03M – 3
2015
Q4 		$1.03M Buy
+10,196
New +$1.06M 0.15% 5
2015
Q3 		– Sell
-3,844
Closed -$450K – 97
2015
Q2 		$450K Buy
+3,844
New +$420K 0.04% 134
2014
Q4 		– Sell
-7,934
Closed -$845K – 195
2014
Q3 		$845K Sell
7,934
-3,835
-33% -$376K 0.09% 72
2014
Q2 		$976K Buy
+11,769
New +$916K 0.11% 58
2013
Q4 		– Sell
-115,003
Closed -$7.23M – 433
2013
Q3 		$7.23M Buy
115,003
+379
+0.3% +$22.7K 0.58% 25
2013
Q2 		$5.88M Buy
+114,624
New +$5.97M 0.54% 25

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Maple Securities USA's GILD Position: Q1 2016 in Review

Maple Securities USA sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 10,196 shares — an estimated $1.03M sold.

Maple Securities USA first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $7.23M in Q3 2013. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Maple Securities USA reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Maple Securities USA sold 10,196 Gilead Sciences shares in Q1 2016, an estimated $1.03M.
  • Maple Securities USA first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Maple Securities USA's Gilead Sciences position peaked at $7.23M in Q3 2013.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Maple Securities USA's 13F filing for Q1 2016.